PharmaLogic announced today that it opened a new radiopharmaceutical production and research facility in Salt Lake City. The new state-of-the-art facility marks “a major step forward” in the CDMO’s mission to deliver diagnostic and therapeutic radiopharmaceuticals to patients across North America, according to a news release. PharmaLogic said it chose to establish the facility in…
Lantheus sells radiopharmacy and PET manufacturing facility to PharmaLogic
Lantheus Holdings (NASDAQ:LNTH) has agreed to sell its Puerto Rico-based radiopharmacy and positron emission tomography manufacturing facility to PharmaLogic Holdings Corp. PharmaLogic will pay $18 million to acquire the assets. The two companies also agreed to enter into a long-term supply agreement in which Lantheus will supply PharmaLogic with a range of products. The transaction…